Canaccord Genuity Maintains a 'Buy' on Momenta Pharmaceuticals (MNTA); Dark Horse Amphastar Enox Approved: Other Shoe Drops
Tweet
Share
E-mailGet Alerts MNTA Hot Sheet
Price: $52.48 --0%
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
8 Buy, 11 Hold, 2 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Canaccord Genuity maintains a 'Buy' on Momenta Pharmaceuticals (NASDAQ: MNTA), slashes price target from $27 to $15.
Canaccord analyst, Ritu Baral, said, "We think m-enox sales revenue to MNTA will decline rapidly from Q4/11 on Amphastar’s enox approval. We still think MNTA/Sandoz has a strong case in the ongoing Teva generic Copaxone infringement suit and that MNTA will become a biosimilars development leader. We are lowering our price target to $15 from $27 based on lower me-enox sales and higher discount rate to reflect higher market and commercial risk."
For more ratings news on Momenta Pharmaceuticals click here and for the rating history of Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $12.30 yesterday.
Canaccord analyst, Ritu Baral, said, "We think m-enox sales revenue to MNTA will decline rapidly from Q4/11 on Amphastar’s enox approval. We still think MNTA/Sandoz has a strong case in the ongoing Teva generic Copaxone infringement suit and that MNTA will become a biosimilars development leader. We are lowering our price target to $15 from $27 based on lower me-enox sales and higher discount rate to reflect higher market and commercial risk."
For more ratings news on Momenta Pharmaceuticals click here and for the rating history of Momenta Pharmaceuticals click here.
Shares of Momenta Pharmaceuticals closed at $12.30 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Advance Auto Parts (AAP) PT Lowered to $48 at DA Davidson Following 25% Selloff Post Q2 Results
- Deere (DE) PT Raised to $585 at JPMorgan
- Cummins (CMI) PT Lowered to $675 at Jefferies
Create E-mail Alert Related Categories
Analyst Comments, FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
